| PMAQX | PMBMX | PMAQX / PMBMX | |
| Total Expense Ratio | 0.57 | 1.13 | 50% |
| Annual Report Gross Expense Ratio | 0.57 | 1.13 | 50% |
| Fund Existence | 10 years | 26 years | - |
| Gain YTD | -7.830 | -8.059 | 97% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 23.8B | 23.8B | 100% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | -14.13 | -15.10 | 94% |
| Returns for 3 years | 14.93 | 11.86 | 126% |
| Returns for 5 years | -1.11 | -5.56 | 20% |
| Returns for 10 years | N/A | 72.14 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MSMIX | 33.68 | 0.26 | +0.78% |
| NYLI WMC Value Investor Class | |||
| VFSNX | 290.53 | N/A | N/A |
| Vanguard FTSE All-Wld ex-US SmCp Idx Ins | |||
| IVGTX | 9.95 | N/A | N/A |
| VY® Morgan Stanley Global Franchise S | |||
| EMFIX | 17.25 | N/A | N/A |
| Ashmore Emerging Markets Equity Instl | |||
| GAOTX | 21.22 | N/A | N/A |
| JPMorgan Global Allocation R3 | |||